Reduction in all-cause mortality and morbidity with candesartan in patients with chronic heart failure and systolic left ventricular dysfunction: results of the CHARM low EF trials

✍ Scribed by James B. Young; Karl Swedberg; Mark E. Dunlap; Marc A. Pfeffer; Jeffrey L. Probstfield; Christopher B. Granger; Robert S. McKelvey; John J.V. McMurray; Eric L. Michaelson; Bertil Olofsson; Jan Ostergren; Salim Yusuf

• Book ID: 119212399
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 59 KB
• Volume: 10
• Category: Article
• ISSN: 1532-8414
• DOI: 10.1016/j.cardfail.2004.06.212